Resmed Cdi revenue and financials
$31.78Change from previous close: −0.69%Absolute change: −$0.22
In the fiscal year ended June 2026, Resmed Cdi reported revenue of $5.65B (+9.85% year over year). Net income was $1.52B, a net margin of 26.9%.
Fiscal year ending in June. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +9.85%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +8.75%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 26.9%
- FY to Jun 2025: 27.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 |
|---|---|---|---|---|---|
| Total assets | 8,966 | 8,174 | 6,872 | 6,752 | — |
| Current assets | 4,325 | 3,506 | 2,358 | 2,368 | — |
| Cash and equivalents | 1,469 | 1,209 | 238 | 228 | — |
| Receivables | 1,085 | 991 | 875 | 705 | — |
| Inventory | 946 | 928 | 822 | 998 | — |
| Net property, plant and equipment | 735 | 718 | 699 | 666 | — |
| Goodwill | 2,910 | 3,047 | 2,842 | 2,770 | — |
| Other intangible assets | 453 | 465 | 486 | 552 | — |
| Current liabilities | 1,395 | 1,019 | 911 | 759 | — |
| Accounts payable | 309 | 278 | 238 | 151 | — |
| Long-term debt | 399 | 658 | 697 | 1,431 | — |
| Total debt | 826 | 852 | 874 | 1,580 | — |
| Total liabilities | 2,381 | 2,207 | 2,008 | 2,622 | — |
| Total equity (incl. minority) | 6,585 | 5,968 | 4,864 | 4,130 | — |
| Retained earnings | 7,255 | 6,081 | 4,992 | 4,253 | — |